The antitumor and immunoadjuvant effects of IFN-α in combination with recombinant poxvirus vaccines

Keyphrases

• Adenocarcinoma 16%
• Antigen Presentation 16%
• Antigen-specific CTL 16%
• Antitumor 100%
• Biological Response Modifiers 16%
• Carcinoembryonic Antigen 100%
• Carcinoma 16%
• CD8+ 16%
• Cell Toxicity 16%
• Clinical Trials 16%
• Colorectal Adenocarcinoma 16%
• CTL Activity 16%
• CTL Response 16%
• Functional Impact 16%
• Immunoadjuvant 100%
• Immunotherapeutic Strategy 16%
• Improved Survival 16%
• Interferon-α (IFN-α) 16%
• Locoregional 16%
• Mechanistic Insight 16%
• Mechanistic Studies 16%
• Murine Model 16%
• Natural Killer 16%
• Pancreatic Adenocarcinoma 16%
• Pancreatic Tumor 16%
• Phenotypic Effects 16%
• Pleiotropic Cytokine 16%
• Poxvirus 16%
• Recombinant 16%
• Therapeutic Vaccine 16%
• Transgenic Mice 16%
• Tumor 16%
• Tumor Growth 33%
• Tumor-free 16%
• Vaccination 33%
• Vaccinia Virus 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Poxviridae 16%
• Poxvirus Vaccine 100%
• Tumor Vaccine 16%
• Vaccinia virus 16%

Immunology and Microbiology

• Cell Mediated Cytotoxicity 16%
• Inguinal Lymph Node 33%
• Tumor Vaccine 16%